BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 30384117)

  • 1. Safety and feasibility of low-dose fluorescein-guided resection of glioblastoma.
    Fan C; Jiang Y; Liu R; Wu G; Wu G; Xu K; Miao Z
    Clin Neurol Neurosurg; 2018 Dec; 175():57-60. PubMed ID: 30384117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Safety of Ultra-low-dose Fluorescein Sodium-Guided Resection of Malignant Glioma.
    Ling G; Guo T; Guo F; Piao H
    World Neurosurg; 2024 May; 185():e774-e785. PubMed ID: 38432505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescein-Guided Surgery for Malignant Gliomas.
    Dellaretti M; Melo MT; Faraj de Lima FB; Guazzelli S; Costa BBR; Pereira PSS; Torres RE
    World Neurosurg; 2023 Jun; 174():62. PubMed ID: 36906086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Application of Sodium Fluorescein in Resection of Medulloblastoma Under YELLOW 560 Filter: Feasibility and Preliminary Results of a Monocentric Cohort and Systematic Review.
    Falco J; Broggi M; Rubiu E; Schiariti M; Restelli F; Mazzapicchi E; La Corte E; Ferroli P; Acerbi F
    World Neurosurg; 2024 Mar; 183():e386-e394. PubMed ID: 38154682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximizing Extent of Resection for Noneloquent Glioblastoma: Fluorescent Dye or Intraoperative Magnetic Resonance Imaging?
    Banu MA; McKhann GM
    J Clin Oncol; 2023 Dec; 41(36):5493-5496. PubMed ID: 37722089
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraoperative Magnetic Resonance Imaging (MRI)-Guided Resection of Glioblastoma: A Meta-Analysis of 1,847 Patients.
    Pichardo-Rojas PS; Angulo-Lozano JC; Alvarez-Castro JA; Vázquez-Alva D; Osuna-Lau RA; Choque-Ayala LC; Tandon N; Esquenazi Y
    World Neurosurg; 2024 Feb; 182():e807-e822. PubMed ID: 38101537
    [No Abstract]   [Full Text] [Related]  

  • 7. What have we learned in fluorescein-guided resection of brain metastases? An update after 79 consecutive cases.
    Falco J; Broggi M; Rubiu E; Restelli F; Pollo B; Schiariti M; Lanteri P; Stanziano M; LA Corte E; Mazzapicchi E; Vetrano IG; Ferroli P; Acerbi F
    J Neurosurg Sci; 2023 Nov; ():. PubMed ID: 37971496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescein-guided resection of a left frontal pre-rolandic cerebral metastasis: how I do it.
    Acerbi F; Broggi M; Ferroli P; Falco J
    Acta Neurochir (Wien); 2023 Sep; 165(9):2519-2524. PubMed ID: 37284838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the sodium fluorescein yellow fluorescence boundary and the actual boundary of high-grade gliomas during surgical resection.
    Chen ZB; Zhu XP; Zheng W; Xiang Y; Huang YK; Fang HJ; Deng AJ; Yi FR; Chen HW; Han DQ; Lv SQ
    Br J Neurosurg; 2021 Sep; ():1-8. PubMed ID: 34542381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium fluorescein uptake by the tumor microenvironment in human gliomas and brain metastases.
    Musca B; Bonaudo C; Tushe A; Battaggia G; Russo MG; Silic-Benussi M; Pedone A; Della Puppa A; Mandruzzato S
    J Neurosurg; 2024 Apr; 140(4):958-967. PubMed ID: 37657099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of sodium fluorescein-guided microsurgery on cognitive function, neuropeptide dynamics, and short-term outcomes in brain glioma patients.
    Tan Y; Yu Y; Liao X; Yu L; Lai H; Li X; Wang C; Wu S; Liu C; Feng D
    Am J Cancer Res; 2024; 14(4):1880-1891. PubMed ID: 38726289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-generation agents for fluorescence-guided glioblastoma surgery.
    Chirizzi C; Pellegatta S; Gori A; Falco J; Rubiu E; Acerbi F; Bombelli FB
    Bioeng Transl Med; 2024 May; 9(3):e10608. PubMed ID: 38818124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verbascoside suppresses the migration and invasion of human glioblastoma cells via targeting c-Met-mediated epithelial-mesenchymal transition.
    Hei B; Wang J; Wu G; Ouyang J; Liu RE
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1270-1277. PubMed ID: 31113618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme.
    Höhne J; Schebesch KM; de Laurentis C; Akçakaya MO; Pedersen CB; Brawanski A; Poulsen FR; Kiris T; Cavallo C; Broggi M; Ferroli P; Acerbi F
    World Neurosurg; 2019 May; 125():e158-e164. PubMed ID: 30682505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximal Safe Resection in Glioblastoma Surgery: A Systematic Review of Advanced Intraoperative Image-Guided Techniques.
    Bonosi L; Marrone S; Benigno UE; Buscemi F; Musso S; Porzio M; Silven MP; Torregrossa F; Grasso G
    Brain Sci; 2023 Jan; 13(2):. PubMed ID: 36831759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the intraoperative delineation of malignant glioma margin.
    Jiang S; Chai H; Tang Q
    Front Oncol; 2023; 13():1114450. PubMed ID: 36776293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescein-guided resection for pediatric low-grade gliomas: institutional experience on two cases and a narrative literature review.
    da Costa MDS; Vaz HHS; Silva NA; Dastoli PA; Nicácio JM; Malveira AS; Flores EIB; Cavalheiro S
    Childs Nerv Syst; 2023 Jun; 39(6):1485-1493. PubMed ID: 36454311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative fluorescence molecular imaging accelerates the coming of precision surgery in China.
    Zhang Z; He K; Chi C; Hu Z; Tian J
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2531-2543. PubMed ID: 35230491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence-Guided Surgery for High-Grade Gliomas: State of the Art and New Perspectives.
    Palmieri G; Cofano F; Salvati LF; Monticelli M; Zeppa P; Perna GD; Melcarne A; Altieri R; La Rocca G; Sabatino G; Barbagallo GM; Tartara F; Zenga F; Garbossa D
    Technol Cancer Res Treat; 2021; 20():15330338211021605. PubMed ID: 34212784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium Fluorescein for Spinal Intradural Tumors.
    Olguner SK; Arslan A; Açık V; İstemen İ; Can M; Gezercan Y; Ökten Aİ
    Front Oncol; 2020; 10():618579. PubMed ID: 33585245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.